Source: Annual Congress 2003 - Asthma: inhaled therapy; allergic bronchopulmonary aspergillosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Pistelli, F. Baldari, S. Sammarro (Rome, Italy). The relevance of the delivery system to the efficacy of the association beta2 agonists/steroids in asthma. Eur Respir J 2003; 22: Suppl. 45, 1577

Member's Comments

No comment yet.

Related content which might interest you: Variability and lack of predictive ability of asthma end-points in clinical trials Source: Eur Respir J 2002; 20: 1102-1109 Year: 2002 Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Source: Eur Respir J 2004; 24: 1-2 Year: 2004 Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 A comparative study to evaluate the effects of salmetrol/fluticasone and formoterol/budesonide combinations on lung functions and sleep quality in asthma Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma? Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021 Year: 2021 Impact of spacer use on the efficacy and safety of ciclesonide MDI in children with persistent asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Asthma management - The role of drug delivery Source: Annual Congress 2005 - Asthma management - important issues Year: 2005 Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 A novel asthma monitoring system for asthma management in children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005 Relationship between omalizumab efficacy and baseline allergen profile impacts patient-reported outcomes in allergic asthma Source: International Congress 2018 – Tests and trends in asthma Year: 2018 The ability of fluctuation analysis of airway function and symptoms to asses asthma stability in different asthma phenotypes Source: Eur Respir J 2007; 30: Suppl. 51, 257s Year: 2007 Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 Year: 2018 Ease of use of inhalers and its impact on treatment adherence and control of asthma. An observational study Source: International Congress 2017 – Inhalers and their use Year: 2017 Methacoline challenge response in controlled asthma and correlations with other disease characteristics Source: Annual Congress 2012 - Asthma management Year: 2012 An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD Source: Eur Respir J, 52 (5) 1801675; 10.1183/13993003.01675-2018 Year: 2018 Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma Source: Eur Respir J 2006; 28: 1042-1050 Year: 2006 Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006 The impact of different asthma phenotypes on the outcome Source: Annual Congress 2012 - Asthma from childhood to adulthood: what factors predict the outcome? Year: 2012